Novartis (ADR)
Develops innovative medicines across four therapeutic areas and multiple advanced technology platforms.
$153.81
After-hours close0.00 (0.00%)
At close$153.81(−0.54%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Oct 2026 | $2.24 | — | — |
| Jul 2026 | $2.17 | $2.41 | +11.1% |
| Apr 2026 | $2.11 | $1.99 | −5.7% |
| Feb 2026 | $1.99 | $2.03 | +2.0% |
| Oct 2025 | $2.26 | $2.25 | −0.4% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Jul 2025 | |||
| Apr 2025 | |||
| Jan 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| Apr 2024 | |||
| Jan 2024 | |||
| Oct 2023 | |||
| Jul 2023 | |||
| Apr 2023 | |||
| Feb 2023 | |||
| Oct 2022 | |||
| Jul 2022 | |||
| Apr 2022 | |||
| Feb 2022 | |||
| Oct 2021 | |||
| Jul 2021 | |||
| Apr 2021 | |||
| Jan 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Jan 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| Apr 2019 | |||
| Jan 2019 | |||
| Oct 2018 | |||
| Jul 2018 | |||
| Apr 2018 | |||
| Jan 2018 | |||
| Oct 2017 | |||
| Jul 2017 | |||
| Apr 2017 | |||
| Jan 2017 | |||
| Oct 2016 | |||
| Jul 2016 | |||
| Apr 2016 | |||
| Jan 2016 | |||
| Oct 2015 | |||
| Jul 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Oct 27, 2026 | $2.24 | — | — | $14.59B | — | — |
| Jul 21, 2026 | $2.17 | $2.41 | +11.1% | $14.07B | $14.41B | +2.4% |
| Apr 28, 2026 | $2.11 | $1.99 | −5.7% | $13.44B | $13.11B | −2.4% |
| Feb 4, 2026 | $1.99 | $2.03 | +2.0% | $13.70B | $13.34B | −2.7% |
| Oct 28, 2025 | $2.26 | $2.25 | −0.4% | $13.64B | $14.36B | +5.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Jul 17, 2025 | ||||||
| Apr 29, 2025 | ||||||
| Jan 31, 2025 | ||||||
| Oct 29, 2024 | ||||||
| Jul 18, 2024 | ||||||
| Apr 23, 2024 | ||||||
| Jan 31, 2024 | ||||||
| Oct 24, 2023 | ||||||
| Jul 18, 2023 | ||||||
| Apr 25, 2023 | ||||||
| Feb 1, 2023 | ||||||
| Oct 25, 2022 | ||||||
| Jul 19, 2022 | ||||||
| Apr 26, 2022 | ||||||
| Feb 2, 2022 | ||||||
| Oct 26, 2021 | ||||||
| Jul 21, 2021 | ||||||
| Apr 27, 2021 | ||||||
| Jan 26, 2021 | ||||||
| Oct 27, 2020 | ||||||
| Jul 21, 2020 | ||||||
| Apr 28, 2020 | ||||||
| Jan 29, 2020 | ||||||
| Oct 22, 2019 | ||||||
| Jul 18, 2019 | ||||||
| Apr 24, 2019 | ||||||
| Jan 30, 2019 | ||||||
| Oct 18, 2018 | ||||||
| Jul 18, 2018 | ||||||
| Apr 19, 2018 | ||||||
| Jan 24, 2018 | ||||||
| Oct 24, 2017 | ||||||
| Jul 18, 2017 | ||||||
| Apr 25, 2017 | ||||||
| Jan 25, 2017 | ||||||
| Oct 25, 2016 | ||||||
| Jul 19, 2016 | ||||||
| Apr 21, 2016 | ||||||
| Jan 27, 2016 | ||||||
| Oct 27, 2015 | ||||||
| Jul 21, 2015 | ||||||